PMID- 14684182 OWN - NLM STAT- MEDLINE DCOM- 20040210 LR - 20220225 IS - 0006-291X (Print) IS - 0006-291X (Linking) VI - 313 IP - 2 DP - 2004 Jan 9 TI - mTOR integrates amino acid- and energy-sensing pathways. PG - 443-6 AB - The AMP-activated protein kinase (AMPK) exists as a heterotrimetric complex comprising a catalytic alpha subunit and non-catalytic beta and gamma subunits. Under conditions of hypoxia, exercise, ischemia, heat shock, and low glucose, AMPK is activated allosterically by rising cellular AMP and by phosphorylation of the catalytic alpha subunit. The mammalian target of rapamycin (mTOR) controls cellular functions in response to amino acids and growth factors. Recent reports including our study have demonstrated the possible interplay between mTOR and AMPK signaling pathways, supporting a model in which mitochondrial dysfunction caused by the mitochondrial inhibitors or ATP depletion inhibits activation of p70 S6 kinase alpha (p70alpha), a downstream effector of mTOR, by activating AMPK. Leucine may stimulate p70alpha phosphorylation via mTOR pathway, in part, by serving both as a mitochondrial fuel through oxidative carboxylation and an allosteric activation of glutamate dehydrogenase. This hypothesis may support an idea in which leucine modulates mTOR function, in part by regulating mitochondrial function and AMPK. Further understanding of the role of mTOR in coordinating amino acid- and energy-sensing pathways would provide new insights into relationship between nutrients and cellular functions. FAU - Tokunaga, Chiharu AU - Tokunaga C AD - Biosignal Research Center, Kobe University, Kobe 657-8501, Japan. FAU - Yoshino, Ken-ichi AU - Yoshino K FAU - Yonezawa, Kazuyoshi AU - Yonezawa K LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Review PL - United States TA - Biochem Biophys Res Commun JT - Biochemical and biophysical research communications JID - 0372516 RN - 0 (Amino Acids) RN - 0 (Multienzyme Complexes) RN - EC 2.7.- (Protein Kinases) RN - EC 2.7.1.1 (MTOR protein, human) RN - EC 2.7.11.1 (Protein Serine-Threonine Kinases) RN - EC 2.7.11.1 (TOR Serine-Threonine Kinases) RN - EC 2.7.11.31 (AMP-Activated Protein Kinases) RN - GMW67QNF9C (Leucine) RN - IY9XDZ35W2 (Glucose) SB - IM MH - AMP-Activated Protein Kinases MH - Amino Acids/*metabolism MH - Animals MH - Energy Metabolism/*physiology MH - Glucose/metabolism MH - Humans MH - Leucine/metabolism MH - Mitochondria/metabolism MH - Multienzyme Complexes/chemistry/metabolism MH - Protein Kinases/*metabolism MH - Protein Serine-Threonine Kinases/chemistry/metabolism MH - Signal Transduction MH - TOR Serine-Threonine Kinases RF - 20 EDAT- 2003/12/20 05:00 MHDA- 2004/02/11 05:00 CRDT- 2003/12/20 05:00 PHST- 2003/12/20 05:00 [pubmed] PHST- 2004/02/11 05:00 [medline] PHST- 2003/12/20 05:00 [entrez] AID - S0006291X03023465 [pii] AID - 10.1016/j.bbrc.2003.07.019 [doi] PST - ppublish SO - Biochem Biophys Res Commun. 2004 Jan 9;313(2):443-6. doi: 10.1016/j.bbrc.2003.07.019.